L&C Bio Co., Ltd (290650.KQ)

KRW 22450.0

(-1.54%)

Total Assets Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual total assets in 2023 was 262.23 Billion KRW , up 31.3% from previous year.
L&C Bio Co., Ltd's latest quarterly total assets in 2024 Q2 was 257.96 Billion KRW , down -2.52% from previous quarter.
L&C Bio Co., Ltd reported annual total assets of 199.72 Billion KRW in 2022, up 85.96% from previous year.
L&C Bio Co., Ltd reported annual total assets of 107.4 Billion KRW in 2021, up 33.29% from previous year.
L&C Bio Co., Ltd reported quarterly total assets of 264.64 Billion KRW for 2024 Q1, up 0.92% from previous quarter.
L&C Bio Co., Ltd reported quarterly total assets of 209.56 Billion KRW for 2023 Q2, up 2.23% from previous quarter.

Annual Total Assets Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Total Assets of L&C Bio Co., Ltd (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	262.23 Billion KRW	31.3%
2022	199.72 Billion KRW	85.96%
2021	107.4 Billion KRW	33.29%
2020	80.57 Billion KRW	21.67%
2019	66.22 Billion KRW	15.42%
2018	57.37 Billion KRW	180.03%
2017	20.49 Billion KRW	30.84%
2016	15.66 Billion KRW	71.88%
2015	9.11 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	257.96 Billion KRW	-2.52%
2024 Q1	264.64 Billion KRW	0.92%
2023 Q2	209.56 Billion KRW	2.23%
2023 Q4	262.23 Billion KRW	-1.62%
2023 FY	262.23 Billion KRW	31.3%
2023 Q1	204.99 Billion KRW	2.64%
2023 Q3	266.54 Billion KRW	27.19%
2022 FY	199.72 Billion KRW	85.96%
2022 Q4	199.72 Billion KRW	2.17%
2022 Q3	195.48 Billion KRW	4.73%
2022 Q2	186.65 Billion KRW	62.99%
2022 Q1	114.51 Billion KRW	6.62%
2021 Q1	84.84 Billion KRW	5.3%
2021 Q4	107.4 Billion KRW	15.26%
2021 Q3	93.18 Billion KRW	8.64%
2021 Q2	85.77 Billion KRW	1.09%
2021 FY	107.4 Billion KRW	33.29%
2020 FY	80.57 Billion KRW	21.67%
2020 Q3	74.94 Billion KRW	2.19%
2020 Q4	80.57 Billion KRW	7.52%
2020 Q2	73.33 Billion KRW	-11.6%
2020 Q1	82.95 Billion KRW	25.26%
2019 Q3	64.8 Billion KRW	3.28%
2019 Q4	66.22 Billion KRW	2.2%
2019 FY	66.22 Billion KRW	15.42%
2019 Q2	62.74 Billion KRW	2.95%
2019 Q1	60.94 Billion KRW	6.21%
2018 Q2	31.41 Billion KRW	0.0%
2018 FY	57.37 Billion KRW	180.03%
2018 Q4	57.37 Billion KRW	0.0%
2017 Q4	20.49 Billion KRW	0.0%
2017 FY	20.49 Billion KRW	30.84%
2016 FY	15.66 Billion KRW	71.88%
2015 FY	9.11 Billion KRW	0.0%

Peer Total Assets Comparison of L&C Bio Co., Ltd

Name	Total Assets	Total Assets Difference
Osang Healthcare Co.,Ltd	320.54 Billion KRW	18.193%
InBody Co.,Ltd	274.45 Billion KRW	4.455%
Curexo Inc.	107.36 Billion KRW	-144.231%
Seegene, Inc.	1251.45 Billion KRW	79.046%
i-SENS, Inc.	498.81 Billion KRW	47.43%
Ray Co., Ltd.	259.55 Billion KRW	-1.032%
Gencurix Inc.	33.5 Billion KRW	-682.732%
Sugentech Inc.	133.18 Billion KRW	-96.889%